Disseminated Intravascular Coagulation (DIC) Score and Organ Dysfunction in Septic Shock Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorSanjay Gandhi Postgraduate Institute of Medical Sciences

About this trial

Septic shock is common complication in patients with critical illnesses, with higher incidence in low and medium income countries like ours. Disseminated intravascular coagulation (DIC) is also common in patients presenting to intensive care units. Further DIC is common coexisting condition seen in many patients presenting with sepsis and septic shock.

Both DIC and septic shock individually are associated with very high mortality and morbidity and coexistence of both increase risk manifold. Organ dysfunction is a complication of both septic shock and DIC individually and in presence of coexistence risk further multiply. DIC scoring of every patient at risk as in patients presenting with septic shock help us to predict about patients having more chances to convert to overt DIC.

Understanding effects of DIC on organ dysfunction in septic shock patients can help to prognosticate and guide towards early intervention. Also, there is paucity of literature on effect of DIC score changes on organ dysfunction in patients with septic shock.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult ICU patients having septic shock as defined by Sepsis -3 definition requiring vasopressor for at least 12 hours duration will be considered.

Disqualifiers

Patient having septic shock duration either less than 12 hours or more than 24 hours at the time of the inclusion

Age less than 18 years or more than 65 years

Expected survival less than 72 hours

Caregiver refused for the consent to participate in the study

Trial population

Adult ICU patients having septic shock as defined by Sepsis -3 definition requiring vasopressor for at least 12 hours duration will be considered.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

60 Participants
are grouped into 1 trial group
Group A: Septic shock

Trial outcomes

Primary outcomes

1

Effect of Disseminated Intravascular Coagulation score changes on organ dysfunction in septic shock patients at day 7

Correlation of Disseminated Intravascular Coagulation score (0 to 8, where higher score is severe) and its change with the organ dysfunction measured as Sequential Organ Failure Assessment score (0 to 24, where higher score has worse outcome)

Time frame
At day 7 after inclusion

Secondary outcomes

1

Effect of Disseminated Intravascular Coagulation score changes on organ dysfunction in septic shock patients at day 14

Correlation of Disseminated Intravascular Coagulation score (0 to 8, where higher score is severe) and its change with the organ dysfunction measured as Sequential Organ Failure Assessment score (0 to 24, where higher score has worse outcome)

Time frame
At day 14 after inclusion

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.